Published in Vaccine Weekly, March 10th, 1997
A detailed presentation of the clinical trial results was given by the study's principal clinical investigators, Dr. Pierre L. Triozzi, the Ohio State University, at the joint meeting of the American Academy of Allergy, Asthma, and Immunology, the American Association of Immunologists, and the Clinical Immunology Society. The Phase I trial was conducted under contract with the Ohio State University Research Foundation.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.